Nuvation Bio, Inc. (NUVB)
5.85
-0.29
(-4.72%)
USD |
NYSE |
Jan 16, 16:00
5.85
0.00 (0.00%)
Pre-Market: 20:00
Nuvation Bio Total Assets (Quarterly): 601.56M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Indivior PLC | 1.416B |
| Terns Pharmaceuticals, Inc. | 301.65M |
| GRAIL, Inc. | 2.601B |
| Arrowhead Pharmaceuticals, Inc. | 1.450B |
| Corcept Therapeutics, Inc. | 823.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 275.68M |
| Shareholders Equity (Quarterly) | 325.88M |
| Debt to Equity Ratio | 0.6387 |
| Current Ratio | 8.477 |
| Net Debt Paydown Yield | 1.28% |